{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T15:47:56Z","timestamp":1779205676644,"version":"3.51.4"},"reference-count":51,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.biopsych.2013.02.020","type":"journal-article","created":{"date-parts":[[2013,4,3]],"date-time":"2013-04-03T05:01:56Z","timestamp":1364965316000},"page":"734-741","source":"Crossref","is-referenced-by-count":125,"title":["Inhibition of Glycine Transporter-I as a Novel Mechanism for the Treatment of Depression"],"prefix":"10.1016","volume":"74","author":[{"given":"Chih-Chia","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I-Hua","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chieh-Liang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuang-Ti","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mang-Hung","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priscilla","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rene","family":"Tun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuo-Hao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue-Cune","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsien-Yuan","family":"Lane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guochuan Emil","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2013.02.020_bib1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1001\/archpsyc.1994.03950010008002","article-title":"Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey","volume":"51","author":"Kessler","year":"1994","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2013.02.020_bib2","series-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"1994"},{"key":"10.1016\/j.biopsych.2013.02.020_bib3","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1001\/archpsyc.1992.01820100053010","article-title":"Time to recovery, chronicity, and levels of psychopathology in major depression: A 5-year prospective follow-up of 431 subjects","volume":"49","author":"Keller","year":"1992","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2013.02.020_bib4","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1176\/ajp.115.11.1025","article-title":"Cycloserine as an antidepressant agent","volume":"115","author":"Crane","year":"1959","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2013.02.020_bib5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1378\/chest.29.3.241","article-title":"The treatment of human tuberculosis with cycloserine","volume":"29","author":"Epstein","year":"1955","journal-title":"Prog Rep Dis Chest"},{"key":"10.1016\/j.biopsych.2013.02.020_bib6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/archpsyc.56.1.29","article-title":"Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia","volume":"56","author":"Heresco-Levy","year":"1999","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2013.02.020_bib7","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.biopsych.2003.09.012","article-title":"Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to antipsychotics for the treatment of schizophrenia","volume":"55","author":"Tsai","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2013.02.020_bib8","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1001\/archpsyc.62.11.1196","article-title":"Sarcosine or D-serine add-on treatment for acute exacerbation of schizophrenia: a randomized, double-blind, placebo-controlled study","volume":"62","author":"Lane","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2013.02.020_bib9","doi-asserted-by":"crossref","first-page":"522","DOI":"10.2174\/138161210790361452","article-title":"Strategies to enhance N-methyl-D-aspartate receptor-mediated neurotransmission in schizophrenia, a critical review and meta-analysis","volume":"16","author":"Tsai","year":"2010","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.biopsych.2013.02.020_bib10","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1038\/sj.npp.1300772","article-title":"Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychotic","volume":"30","author":"Depoort\u00e8re","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2013.02.020_bib11","first-page":"1","article-title":"Acute d-serine treatment produces antidepressant-like effects in rodents","volume":"12","author":"Malkesman","year":"2011","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2013.02.020_bib12","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1038\/sj.npp.1301604","article-title":"Lamina-specific abnormalities of NMDA receptor-associated postsynaptic protein transcripts in the prefrontal cortex in schizophrenia and bipolar disorder","volume":"33","author":"Beneyto","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2013.02.020_bib13","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0006-8993(95)00057-W","article-title":"Alterations in the N-methyl-D-aspartate (NMDA) receptor complex in the frontal cortex of suicide victims","volume":"675","author":"Nowak","year":"1995","journal-title":"Brain Res"},{"key":"10.1016\/j.biopsych.2013.02.020_bib14","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1017\/S1092852900010403","article-title":"Beyond monoamines: glutamatergic function in mood disorders","volume":"10","author":"Kugaya","year":"2005","journal-title":"CNS Spectr"},{"key":"10.1016\/j.biopsych.2013.02.020_bib15","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2013.02.020_bib16","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/archgenpsychiatry.2010.90","article-title":"A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression","volume":"67","author":"Diazgranados","year":"2010","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2013.02.020_bib17","series-title":"Structured Clinical Interview for DSM-IV","year":"1994"},{"key":"10.1016\/j.biopsych.2013.02.020_bib18","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.biopsych.2013.02.020_bib19","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.biopsych.2006.04.005","article-title":"Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to clozapine for the treatment of schizophrenia","volume":"60","author":"Lane","year":"2006","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2013.02.020_bib20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.biopsych.2007.04.038","article-title":"Sarcosine (N-methylglycine) treatment for acute schizophrenia: A randomized, double-blind study","volume":"63","author":"Lane","year":"2008","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2013.02.020_bib21","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1017\/S1461145709990939","article-title":"A randomized, double-blind, placebo-controlled comparison study of sarcosine (N-methylglycine) and D-serine add-on treatment for schizophrenia","volume":"13","author":"Lane","year":"2010","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2013.02.020_bib22","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/archpsyc.1991.01810330075011","article-title":"Conceptualization and rationale for consensus definitions of terms in major depressive disorder: Remission, recovery, relapse, and recurrence","volume":"48","author":"Frank","year":"1991","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2013.02.020_bib23","series-title":"ECDEU Assessment Manual for Psychopharmacology","author":"Guy","year":"1976"},{"key":"10.1016\/j.biopsych.2013.02.020_bib24","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.4088\/JCP.v66n0816","article-title":"Symptom clusters as predictors of late response to antidepressant treatment","volume":"66","author":"Trivedi","year":"2005","journal-title":"J Clin Psychiatry"},{"issue":"Suppl","key":"10.1016\/j.biopsych.2013.02.020_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0447.1987.tb10566.x","article-title":"The UKU Side Effect Rating Scale: A new comprehensive rating scale for psychotropic drugs and cross-sectional study of side effects in neuroleptic-treated patients","volume":"334","author":"Lingjaerde","year":"1987","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.biopsych.2013.02.020_bib26","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0091-3057(95)00138-M","article-title":"Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety","volume":"52","author":"Rodgers","year":"1995","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.biopsych.2013.02.020_bib27","doi-asserted-by":"crossref","first-page":"841","DOI":"10.4088\/JCP.v61n1106","article-title":"A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder","volume":"61","author":"Calabrese","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.biopsych.2013.02.020_bib28","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/oxfordjournals.aje.a009511","article-title":"Comparison of population-averaged and subject-specific approaches for analyzing repeated binary outcomes","volume":"147","author":"Hu","year":"1998","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.biopsych.2013.02.020_bib29","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0014-2999(78)90118-8","article-title":"Behavioural despair in rats: A new model sensitive to antidepressant treatments","volume":"47","author":"Porsolt","year":"1978","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.biopsych.2013.02.020_bib30","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1152\/jn.00680.2002","article-title":"Glycine tranporter-1 blockade potentiates NMDA-mediated responses in rat prefrontal cortical neurons in vitro and in vivo","volume":"89","author":"Chen","year":"2003","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.biopsych.2013.02.020_bib31","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0893-133X(02)00312-3","article-title":"The gerbil elevated plus-maze, I: Behavioral characterization and pharmacological validation","volume":"27","author":"Varty","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2013.02.020_bib32","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0165-6147(02)02017-5","article-title":"Assessing antidepressant activity in rodents: Recent developments and future needs","volume":"23","author":"Cryan","year":"2002","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.biopsych.2013.02.020_bib33","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.biopsych.2007.05.028","article-title":"Cellular mechanisms underlying the antidepressant effects of ketamine: Role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors","volume":"63","author":"Maeng","year":"2008","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2013.02.020_bib34","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3109\/10673229.2010.511059","article-title":"Glutamatergic modulators: the future of treating mood disorders?","volume":"18","author":"Zarate","year":"2010","journal-title":"Harv Rev Psychiatry"},{"key":"10.1016\/j.biopsych.2013.02.020_bib35","series-title":"In: Biological Psychology: An Introduction to Behavioral, Cognitive, and Clinical Neuroscience","article-title":"Learning and memory","author":"Breedlove","year":"2010"},{"key":"10.1016\/j.biopsych.2013.02.020_bib36","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nrn2911","article-title":"Synaptic versus extrasynaptic NMDA receptor signalling: Implications for neurodegenerative disorders","volume":"11","author":"Hardingham","year":"2010","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.biopsych.2013.02.020_bib37","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/nature07762","article-title":"Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression","volume":"457","author":"Sreekumar","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2013.02.020_bib38","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.eururo.2010.01.035","article-title":"Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours","volume":"58","author":"Jentzmik","year":"2010","journal-title":"Eur Urol"},{"issue":"Pt 3","key":"10.1016\/j.biopsych.2013.02.020_bib39","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1258\/acb.2010.009270","article-title":"Serum sarcosine is not a marker for prostate cancer","volume":"47","author":"Struys","year":"2010","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.biopsych.2013.02.020_bib40","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1373\/clinchem.2009.126870","article-title":"The search for new prostate cancer biomarkers continues","volume":"55","author":"Pavlou","year":"2009","journal-title":"Clin Chem"},{"key":"10.1016\/j.biopsych.2013.02.020_bib41","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0006-3223(98)00279-0","article-title":"D-serine added to antipsychotic for the treatment of schizophrenia","volume":"44","author":"Tsai","year":"1998","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2013.02.020_bib42","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.biopsych.2005.06.032","article-title":"D-alanine added to antipsychotics for the treatment of schizophrenia","volume":"59","author":"Tsai","year":"2006","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2013.02.020_bib43","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jad.2012.01.031","article-title":"Does differential drop-out explain the influence of study design on antidepressant response? A meta-analysis","volume":"140","author":"Rutherford","year":"2012","journal-title":"J Affect Disord"},{"key":"10.1016\/j.biopsych.2013.02.020_bib44","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/S0006-3223(00)00957-4","article-title":"Placebo-controlled comparison of the selective serotonin reuptake inhibitors citalopram and sertraline","volume":"48","author":"Stahl","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2013.02.020_bib45","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0140-6736(09)60046-5","article-title":"Comparative efficacy and acceptability of 12 new-generation antidepressants: A multiple-treatments meta-analysis","volume":"373","author":"Cipriani","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.biopsych.2013.02.020_bib46","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1124\/dmd.31.10.1255","article-title":"Pharmacokinetics of citalopram in relation to genetic polymorphism of CYP2C19","volume":"31","author":"Yu","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.biopsych.2013.02.020_bib47","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/JCP.0b013e31822c091a","article-title":"Fast onset of antidepressant effects of citalopram compared with sertraline in drug-na\u00efve first-episode major depressive disorder in a Chinese population: A 6-week double-blind, randomized comparative study","volume":"31","author":"Hsu","year":"2010","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.biopsych.2013.02.020_bib48","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/JCP.0b013e31822bb0db","article-title":"Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: A randomized, double-blind, controlled study","volume":"31","author":"Lin","year":"2011","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.biopsych.2013.02.020_bib49","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/00005650-198905000-00004","article-title":"Gender bias in psychotropic drug prescribing in primary care","volume":"27","author":"Hohmann","year":"1989","journal-title":"Med Care"},{"key":"10.1016\/j.biopsych.2013.02.020_bib50","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.biopsych.2008.08.014","article-title":"Increased anterior cingulate cortical activity in response to fearful faces: A neurophysiological biomarker that predicts rapid antidepressant response to ketamine","volume":"65","author":"Salvadore","year":"2009","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2013.02.020_bib51","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.jpsychires.2009.04.012","article-title":"Pain sensitivity in major depression and its relationship to central serotoninergic function as reflected by the neuroendocrine response to clomipramine","volume":"43","author":"Kundermann","year":"2009","journal-title":"J Psychiatr Res"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322313001881?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322313001881?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,17]],"date-time":"2018-10-17T13:05:08Z","timestamp":1539781508000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322313001881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":51,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0006322313001881"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2013.02.020","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}